Add Yahoo as a preferred source to see more of our stories on Google. A new dual-target antibody calms overactive immune cells in autoimmune diseases without weakening the body's natural defenses.
Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers like leukemia and ...
Hosted on MSN
Engineered T-cells use natural receptors as 'brakes' to target cancer while sparing healthy tissue
A team of researchers has successfully created more effective immune cells that can fight cancer without damaging healthy tissue. "This story goes back nearly 20 years," says Prof. Paul François. This ...
The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of the body, shipped to a specialized facility, genetically reprogrammed, ...
Researchers at the University of Wisconsin School of Veterinary Medicine have identified a possible way to make longer ...
A promising breakthrough in autoimmune disease research may open the door to safer and more effective treatments. Scientists have engineered a special antibody that can selectively calm the immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results